Inhibiting induction of heat shock proteins as a strategy to enhance cancer therapy.

Int J Hyperthermia

Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107-5097, USA.

Published: December 2005

AI Article Synopsis

  • Cancer treatments that use thermal therapy and systemic therapies can trigger the production of heat shock proteins, which may reduce the effectiveness of the treatments.
  • These heat shock proteins can inhibit cell death signaling and protect cells from damage, leading to poorer outcomes in cancer therapy.
  • The paper reviews these treatments and suggests methods to minimize the stress response, potentially enhancing cancer treatment effectiveness by promoting more cell death (apoptosis) and tissue damage (necrosis).

Article Abstract

Cancer treatments that incorporate thermal therapy and some systemic therapies induce the production of heat shock or stress proteins. The induced heat shock proteins could lessen the effect of the therapy by inhibiting apoptotic signaling and by acting as molecular chaperones to prevent irreversible cellular damage. Strategies that prevent the induction of heat shock proteins would result in more apoptosis and necrosis, improving the cancer therapy. This paper briefly reviews cancer therapies that induce the stress response, and proposes strategies to reduce the stress response.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02656730500331918DOI Listing

Publication Analysis

Top Keywords

heat shock
16
shock proteins
12
induction heat
8
cancer therapy
8
therapies induce
8
stress response
8
inhibiting induction
4
heat
4
shock
4
proteins
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!